Symptoms, Sites, and Significance of Mycoplasma genitalium in Men Who Have Sex with Men.
Anti-Bacterial Agents
/ pharmacology
Australia
/ epidemiology
Coinfection
Cross-Sectional Studies
Drug Resistance, Bacterial
Homosexuality, Male
Humans
Male
Mycoplasma Infections
/ diagnosis
Mycoplasma genitalium
/ drug effects
Odds Ratio
Prevalence
Public Health Surveillance
Sexually Transmitted Diseases, Bacterial
/ diagnosis
Symptom Assessment
Australia
MSM
Mycoplasma genitalium
antibiotic resistance
antimicrobial resistance
azithromycin
bacteria
men who have sex with men
proctitis
sexually transmitted infections
Journal
Emerging infectious diseases
ISSN: 1080-6059
Titre abrégé: Emerg Infect Dis
Pays: United States
ID NLM: 9508155
Informations de publication
Date de publication:
04 2019
04 2019
Historique:
entrez:
19
3
2019
pubmed:
19
3
2019
medline:
25
12
2019
Statut:
ppublish
Résumé
During 2016-2017, we tested asymptomatic men who have sex with men (MSM) in Melbourne, Australia, for Mycoplasma genitalium and macrolide resistance mutations in urine and anorectal swab specimens by using PCR. We compared M. genitalium detection rates for those asymptomatic men to those for MSM with proctitis and nongonococcal urethritis (NGU) over the same period. Of 1,001 asymptomatic MSM, 95 had M. genitalium; 84.2% were macrolide resistant, and 17% were co-infected with Neisseria gonorrhoeae or Chlamydia trachomatis. Rectal positivity for M. genitalium was 7.0% and urine positivity was 2.7%. M. genitalium was not more commonly detected in the rectums of MSM (n = 355, 5.6%) with symptoms of proctitis over the same period but was more commonly detected in MSM (n = 1,019, 8.1%) with NGU. M. genitalium is common and predominantly macrolide-resistant in asymptomatic MSM. M. genitalium is not associated with proctitis in this population.
Identifiants
pubmed: 30882306
doi: 10.3201/eid2504.181258
pmc: PMC6433010
doi:
Substances chimiques
Anti-Bacterial Agents
0
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
719-727Références
Sex Transm Dis. 2017 Aug;44(8):457-462
pubmed: 28703723
Sex Transm Dis. 2013 Oct;40(10):768-70
pubmed: 24275725
Sex Transm Infect. 2010 Feb;86(1):21-4
pubmed: 19843536
Clin Infect Dis. 2017 Feb 1;64(3):250-256
pubmed: 28011607
J Clin Microbiol. 2016 Dec 28;55(1):321-325
pubmed: 27629896
Sex Transm Dis. 2008 Sep;35(9):797-800
pubmed: 18607317
MMWR Recomm Rep. 2015 Jun 5;64(RR-03):1-137
pubmed: 26042815
Sex Transm Infect. 2018 Sep;94(6):406-410
pubmed: 29567802
Sex Transm Infect. 2018 Dec;94(8):565-567
pubmed: 29101246
Sex Transm Dis. 2018 Aug;45(8):522-526
pubmed: 29465653
Clin Infect Dis. 2015 Aug 1;61(3):418-26
pubmed: 25900174
BMC Infect Dis. 2015 Aug 19;15:343
pubmed: 26286546
Clin Infect Dis. 2018 Feb 10;66(5):796-798
pubmed: 29028993
Sex Transm Infect. 2009 Oct;85(6):432-5
pubmed: 19254902
Clin Microbiol Infect. 2016 Mar;22(3):260-5
pubmed: 26686807
Emerg Infect Dis. 2018 Feb;24(2):328-335
pubmed: 29350154
J Clin Med. 2014 Dec 12;3(4):1386-91
pubmed: 26237608
AIDS. 2009 Mar 13;23(5):611-20
pubmed: 19194271
Sex Transm Infect. 2018 Jun;94(4):255-262
pubmed: 29440466
J Infect Chemother. 2009 Dec;15(6):410-3
pubmed: 20012733
J Clin Microbiol. 2017 Jun;55(6):1915-1919
pubmed: 28381611
J Infect Dis. 2017 Jul 15;216(suppl_2):S396-S405
pubmed: 28838074
BMC Infect Dis. 2014 Jan 27;14:43
pubmed: 24468054
J Clin Microbiol. 2017 Mar;55(3):978-979
pubmed: 28031435
AIDS. 2012 Mar 13;26(5):617-24
pubmed: 22210630